First Trust Advisors
INDV icon

First Trust Advisors’s Indivior Pharmaceuticals INDV Stock Holding History

First Trust Advisors’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Buy
30,765
+9,882
+47% +$358K ﹤0.01% 2158
2026
Q1 		$637K Buy
20,883
+1,763
+9% +$58.2K ﹤0.01% 2301
2025
Q4 		$686K Buy
+19,120
New +$584K ﹤0.01% 2266

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Trust Advisors's INDV Position: Q2 2026 in Review

First Trust Advisors increased its Indivior Pharmaceuticals (INDV) stake by 47% in Q2 2026, buying an estimated $358K and bringing the position to 30,765 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2158.

First Trust Advisors first reported a position in INDV in Q4 2025 and has held it in 3 quarters since. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • First Trust Advisors held 30,765 shares of Indivior Pharmaceuticals worth $1.26M as of Q2 2026.
  • First Trust Advisors bought 9,882 Indivior Pharmaceuticals shares in Q2 2026, an estimated $358K.
  • Indivior Pharmaceuticals made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #2158 holding.
  • First Trust Advisors first reported a position in Indivior Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.